Group One Trading’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,080
Closed -$1K 8449
2022
Q3
$1K Sell
4,080
-3,632
-47% -$1.59K ﹤0.01% 7432
2022
Q2
$6K Sell
7,712
-16,032
-68% -$14.3K ﹤0.01% 7070
2022
Q1
$25K Buy
23,744
+21,225
+843% +$38.6K ﹤0.01% 6627
2021
Q4
$5K Sell
2,519
-32,564
-93% -$78K ﹤0.01% 7674
2021
Q3
$106K Sell
35,083
-4,615
-12% -$16.4K ﹤0.01% 5856
2021
Q2
$155K Sell
39,698
-33,709
-46% -$140K ﹤0.01% 5506
2021
Q1
$372K Buy
73,407
+44,714
+156% +$232K ﹤0.01% 4389
2020
Q4
$117K Sell
28,693
-4,118
-13% -$20.2K ﹤0.01% 4454
2020
Q3
$159K Buy
32,811
+25,456
+346% +$139K ﹤0.01% 3842
2020
Q2
$41K Buy
+7,355
New +$33.7K ﹤0.01% 4488

Group One Trading's AGTC Position: Q4 2022 in Review

Group One Trading sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 4,080 shares — an estimated $1K sold.

Group One Trading first reported a position in AGTC in Q2 2020 and held it in 10 quarters. The position peaked at $372K in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • Group One Trading reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 4,080 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $1K.
  • Group One Trading first reported a position in Applied Genetic Technologies Corporation in Q2 2020 and held it in 10 quarters.
  • Group One Trading's Applied Genetic Technologies Corporation position peaked at $372K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.